ReviewCancer management and research2023

Spotlight on Cemiplimab-rwlc in the Treatment of Non-Small Cell Lung Cancer (NSCLC): Focus on Patient Selection and Considerations.

Jeffrey Ahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.